Skip to main content

Another Asbestos-in-Talc Lawsuit Ends in a Mistrial

Another Asbestos-in-Talc Lawsuit Ends in a Mistrial

Another Asbestos-in-Talc Lawsuit Ends in a Mistrial

Introduction

This is the second time in two weeks that a talcum powder lawsuit has ended in a mistrial. On Tuesday, October 3, 2018, a Los Angeles jury was dismissed as the judge agreed that they failed to arrive at a unanimous decision and were incapable of announcing a verdict in a lawsuit filed by a plaintiff.

The plaintiff who formerly worked as a computer salesman claimed he was diagnosed with mesothelioma due to asbestos exposure. The jury hoped for at least nine votes to reach a conclusion but was stuck with eight to four against Johnson & Johnson.  

Talcum powder lawsuits are currently underway in several state courts across the nation. All with a similar allegation that the asbestos-exposure from talcum use causes mesothelioma and ovarian cancer. The multidistrict litigation (MDL 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation) is presided over by Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman for coordinated pretrial proceedings in the District of New Jersey.

Last month, J&J's Talc supplier Imerys Talc America has agreed to settle the claims made by a plaintiff that years of using their asbestos-contaminated Baby Powder caused her mesothelioma.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!